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Abstract
Background: Laser microdissection microscopy has become a rising tool to assess gene
expression profiles of pure cell populations. Given the low yield of RNA, a second round of
amplification is usually mandatory to yield sufficient amplified-RNA for microarray approaches.
Since amplification induces truncation of RNA molecules, we studied the impact of a second round
of amplification on identification of differentially expressed genes in relation to the probe – poly(A)-
tail distances.
Results: Disagreement was observed between gene expression profiles acquired after a second
round of amplification compared to a single round. Thirty percent of the differentially expressed
genes identified after one round of amplification were not detected after two rounds. These
inconsistent genes have a significant longer probe – poly(A)-tail distance. qRT-PCR on unamplified
RNA confirmed differential expression of genes with a probe – poly(A)-tail distance >500
nucleotides appearing only after one round of amplification.
Conclusion: Our data demonstrate a marked loss of 30% of truly differentially expressed genes
after a second round of amplification. Therefore, we strongly recommend improvement of
amplification procedures and importance of microarray probe design to allow detection of all
differentially expressed genes in case of limited amounts of RNA.
Background
Oligonucleotide microarray technology is a powerful
application to measure genome-wide changes in mRNA
expression levels in various tissue samples or cell lines. In
most studies of tissue samples, whole tissue homogenates
were used for RNA isolation. However, use of whole tissue
homogenates unavoidably results in averaging of expres-
sion levels of different cell types present in the tissue. The
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be masked or even lost because of the surrounding cells.
To circumvent this problem laser microdissection micros-
copy (LDM) has become an important tool since it allows
isolation of pure cell populations from heterogeneous tis-
sue [1]. The disadvantage of LDM is the low yield of RNA.
Currently, a wide range of amplification protocols has
been developed to increase the amount of RNA for micro-
array approaches [2]. The most widely accepted and used
protocol for microarray approaches is the T7 RNA-
polymerase based linear antisense RNA amplification pro-
tocol [3]. Whereas total RNA from whole tissue samples is
often amplified one round before hybridization, a second
round of amplification is generally performed on total
RNA isolated from LDM samples to yield sufficient RNA
for microarray approaches.
There is ongoing discussion on the effect of a second
round of amplification on the reliability of microarray
data. It is known that the amplification procedure can
introduce a bias by truncating the length of the amplified
transcripts due to inefficient cDNA synthesis. In addition,
a second round of cDNA synthesis can result in further
truncation of the 5' ends of the transcripts, due to random
priming at internal sites for the second strand synthesis [4-
8]. However, reproducible results on microarrays were
described with application of additional rounds of ampli-
fication on low amounts of RNA obtained after microdis-
section [6,9,10]. In addition, the effects of an additional
round of amplification on gene expression profiles have
been reported to be minor on the basis of high Pearson
correlation coefficients of all genes (0.85 to 0.94) between
one and two rounds of amplification [4,10,11] and of
consistent numbers of differentially expressed genes
detected between one and two rounds of amplification
[12].
In this study, we investigated the bias of a second round
of amplification on microarray results by comparing two
rounds of amplification with one round using the Agilent
Whole Human Genome platform. In more detail, we
compared the differentially expressed genes identified
after both amplification methods. We hypothesized that
due to further truncation of RNA during the second round
of amplification, a number of differentially expressed
genes remains undetected when the corresponding micro-
array probes are designed too far from the starting point
of amplification, the poly(A)-tail. To test this hypothesis,
we investigated this probe – poly(A)-tail effect on the
identification of genes differentially expressed between
two microdissected tissue samples after two rounds of
amplification in comparison to genes differentially
expressed after one round of amplification. Quantitative
RT-PCR (qRT-PCR) was used to validate the differential
expression of a selection of these genes on unamplified
total RNA from the same microdissected tissue samples.
Results
RNA isolation and amplification
An area of 24.7 × 106 μm2 of tumor cells was microdis-
sected from the tumor sample and 26.5 × 106 μm2 of bron-
chial epithelial cells was microdissected from the
bronchus. A quantity of 349 ng of total RNA was isolated
from the microdissected tumor cells and 257 ng from the
bronchial epithelial cells. RNA quality was sufficient for
both samples (Figure 1). The average yield of amplified
RNA (aRNA) after a single round of amplification with a
100-ng input of total RNA was 14.3 (13.4–15.2) μg aRNA.
From the samples undergoing two rounds of amplifica-
tion, an input of 25 ng total RNA was used for the 1st
round, resulting in an average of 2.7 (2.3–3.0) μg aRNA.
According to the manufacturer's instructions 2 μg aRNA
was used for the 2nd round of amplification, which yielded
an average of 80 (63.8–92.5) μg aRNA. To assess the size
of the aRNA after one and two rounds of amplification,
we analyzed part of the amplified products on agarose gel
(Figure 2). As expected, we observed a marked reduction
in size of the aRNA after two rounds of amplification.
Low agreement between one and two rounds of 
amplification
Principal component analysis (PCA) was applied to iden-
tify factors that explain the most important variations
between our 12 datasets. The first principal component
explained 84.8% of the total variance, caused by the com-
monly observed technical variation between hybridiza-
tions. After this variance was subtracted, the largest
retained components were visualized in a three-dimen-
sional plot (Figure 3). The 2nd principal component,
which explains 5.6% of the total variance, was explained
by the difference between tumor and bronchus. The 3rd
component (3.5%) was explained by the number of
amplification rounds. The 4th component (2.1%) was
explained by the difference in Cy-dye label. The subse-
quent components, less than 1%, could not be explained
by a known factor. Unsupervised clustering of the 12 indi-
vidual datasets showed the same chronological clusters as
found with PCA, that is, the largest difference was
between tumor and bronchus and the second difference
was between the two amplification procedures (data not
shown).
Bland and Altman plots of the duplicate tumor datasets
yielded after one and two rounds of amplification showed
a large variability in datasets between these two different
amplification methods, with wide 95%-limits of agree-
ment of -0.7 to 0.7 (Figure 4). As a comparison, the con-
trol graphs illustrated a much smaller variability within
the same amplification method and much narrower 95%-Page 2 of 13
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systematic biases between the two methods. The Bradley-
Blackwood F test revealed highly significant differences (p
< 0.0001) between the datasets of one and two rounds of
amplification. The Bradley-Blackwood F test also revealed
a highly significant difference (p < 0.0001) between the
datasets of the same amplification method. This expected
significant difference is in line with the large variability of
the first principal component explained by the technical
variation commonly observed between microarray
hybridizations (84.8% in our study). A high average Pear-
son correlation coefficient of 0.88 ± 0.01 was calculated
between one and two rounds of amplification, which is
comparable to previous studies [4,10,11]. The concord-
ance correlation revealed a very low average correlation
coefficient between the datasets of one and two rounds of
amplification (0.09 ± 0.09) indicating a very low agree-
ment between the two amplification methods. In con-
trast, the concordance correlation within the same
amplification method revealed much higher average coef-
ficients, and thus a much higher agreement (0.63 ± 0.05).
Inconsistency in differentially expressed genes between 
one and two rounds of amplification
Differentially expressed genes after one round of amplifi-
cation were selected at a cut-off level of two times the
standard deviation (2×SD) (p < 0.05) according to the for-
mulas described in Methods. 1,312 differentially
expressed genes were identified after one round of ampli-
fication and 1,349 after two rounds. 931 of these genes
(70%) were identified as differentially expressed genes for
both amplification approaches. Application of more strin-
gent cut-off levels revealed an average consistency of 368
(75%) and 153 (72%) differentially expressed genes
between one and two rounds of amplification at a cut-off
level of 3×SD (p < 0.003) and 4×SD (p < 0.0001) respec-
tively. This means that up to 30% of the differentially
expressed genes differ between one and two rounds of
amplification.
Loss of differentially expressed genes due to long probe – 
poly(A)-tail distance
We investigated if the further truncation of RNA mole-
cules after the second round of amplification can explain
the discrepancy observed between genes differentially
expressed in one and two rounds of amplification. There-
fore, we determined the distance of the 60 mer-oligos
(probes) on the Agilent WHG array to the poly(A)-tail of
the corresponding genes (see Additional file 1). The
21,103 determined probe – poly(A)-tail distances showed
a large variation in distance, with a range from 0 to 22,006
nucleotides (nt) and a median distance of 542 nt (Figure
5A). For the 1,312 genes differentially expressed after one
round of amplification, 872 probe – poly(A)-tail dis-
tances were determined. These 872 probe – poly(A)-tail
distances showed a range from 0 to 7,090 nt with a
median of 289 nt, which was significantly different from
the probe – poly(A)-tail distances of all genes (p < 0.0001)
(Figure 5B). For the 1,349 genes differentially expressed
after two rounds of amplification, 839 probe – poly(A)-
tail distances were determined. These 839 probe –
poly(A)-tail distances showed a range from 0 to 7,621 and
a median of 212 nt, which was significantly different from
the probe – poly(A)-tail distances of all genes (p < 0.0001)
Electropherograms of microdissected RNA samplesFigu e 1
Electropherograms of microdissected RNA samples. 
Beside the marker (left peak) the 18 and 28S peaks are visi-
ble. For all samples the 28S is higher than the 18S peak, indi-
cating good quality RNA. A, T1, ratio 28S/18S = 1.9; B, T2, 
ratio 28S/18S = 1.9; C, B, ratio 28S/18S = 1.8.Page 3 of 13
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0.0001).
246 of the 872 differentially expressed genes identified
after one round were not identified as being differentially
expressed after two rounds (~30%). These 246 inconsist-
ent genes showed a significant longer probe – poly(A)-tail
distance as compared to the remaining 626 consistent dif-
ferentially expressed genes (Mann Whitney test, p <
0.0001) (Figure 5C).
Validation of differentially expressed genes by quantitative 
RT-PCR
Ten of the 246 inconsistent genes (lost in two rounds, Fig-
ure 5C) with a probe – poly(A)-tail distance of more than
500 nt were selected for validation with qRT-PCR. qRT-
PCR was performed on unamplified microdissected total
RNA to verify if these genes were truly differentially
expressed between tumor and bronchus (Table 1). As a
control, another 10 genes with a probe – poly(A)-tail dis-
tance of over 500 nt were selected that were consistent dif-
ferentially expressed for both one and two rounds
(persistent in two rounds, Figure 5C). On average, genes
from both amplification groups had comparable probe –
poly(A)-tail distances (average, 1,047 bp; range, 573–
2,530 bp). The relative expression levels of 18 out of 20
genes showed an up- or down regulation of genes between
tumor and bronchus in agreement with the results of the
microarray data (Table 1). Two genes, NCOA7 and B2M,
showed a similar expression level in tumor and bronchus
(0.7 and 1.6 respectively).
Loss of overall signal intensity after two rounds of 
amplification due to long probe – poly(A)-tail distance
We investigated if a long probe – poly(A)-tail distance
negatively influences the overall signal intensity of genes
after two rounds of amplification. An illustrating graph of
this influence is shown in Figure 6. We observed a nega-
tive regression coefficient for both T and B samples that
were significantly different from zero (p < 0.0001), which
indicates that an increase in probe – poly(A)-tail distance
results in a decreased signal intensity after two rounds of
amplification.
Discussion
The goal of this study was to evaluate the effect of a second
round of T7-RNA polymerase-based amplification, specif-
ically on the identification of differentially expressed
genes, using Agilent Whole Human Genome platform.
We found that prolonged probe – poly(A)-tail distances
are related to a linear decrease in signal intensity. Moreo-
ver, we demonstrate a loss of 30% of truly differentially
expressed genes after a second round of RNA amplifica-
tion.
A clear difference between one and two rounds of ampli-
fication was found by several statistical tests as discussed
below. PCA and unsupervised clustering on the 12 indi-
vidual hybridization datasets indicated that the number
of amplification rounds has an obvious effect on meas-
ured signal intensities, which cannot be explained by
expression differences (Figure 3). No variance was found
that was attributable to the duplicate of the tumor sample,
implicating that the same sample, treated independently,
had only a minor effect on the outcome of gene expres-
sion profiles. This consistency in the duplicates indicates
that the amplification procedure itself, as well for one
round as for two rounds, resulted in reproducible gene
expression profiles similar to previous findings [6,9,10].
Despite the relative high Pearson correlation coefficients
between one and two rounds of amplification, compara-
ble to previous studies [4,10,11], concordance correlation
revealed very low coefficients, confirming the observa-
tions from the Bland and Altman plots. The results of
these statistical tests strongly indicate, as expected, a high
agreement within the same amplification method but a
very low agreement between the two amplification meth-
ods.
The microarray technique is usually used by researchers to
identify differentially expressed genes between two differ-
ent RNA samples. Therefore, we investigated the effect of
the amplification bias on the identification of differen-
tially expressed genes between the tumor and bronchus
LDM samples. Equal numbers of differentially expressed
genes were found after one and two rounds of amplifica-
tion, confirming the previous findings of Wang et al. [12].
Agarose gel electrophoresis of amplified RNA samplesFigure 2
Agarose gel electrophoresis of amplified RNA sam-
ples. The average sizes of the aRNA of the duplicate tumor 
samples (T1 and T2) and the bronchus sample (B) is more 
reduced after two rounds (2x) as compared to the average 
aRNA sizes after one round (1x) of amplification.Page 4 of 13
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tially expressed genes demonstrated an inconsistency of
up to 30% between one and two rounds of amplification.
This percentage remained constant at different significant
cut-off levels, indicating that this bias is not due to chance
or introduced by noise but is a consistent factor. Compa-
rable observations of a decrease in overlap of differentially
expressed genes were shown in previous studies where
one or two rounds of amplification were compared with
unamplified RNA [13,14].
Although microarray production companies state that
their selected probes are located close to the poly(A)-tail
of the corresponding transcripts, analysis of the location
of probes on the Agilent WHG arrays revealed a wide
range in probe – poly(A)-tail distances, from 0 to 22,006
nt with a median of 542 nt. We showed a significant linear
decrease in overall signal intensity of genes with an
increase in probe – poly(A)-tail distance (Figure 6). This
decrease in signal intensity is most likely due to the more
prominent truncation of aRNA molecules after two
rounds of amplification (Figure 2). Our results are an
extension of the findings of McClintick et al. who showed
a linearly decreased signal after one round of amplifica-
tion with an increase in probe – poly(A)-tail distances for
the probe sets of the Affymetrix arrays [5].
Genes selected as being differentially expressed based on
one round of amplification, had significant shorter probe
– poly(A)-tail distances as observed for all genes (Figure
5B). In addition, differentially expressed genes after two
rounds demonstrated even shorter probe – poly(A)-tail
distances (p < 0.0001). Analysis of these 30% inconsistent
differentially expressed genes revealed enrichment of
genes with long probe – poly(A)-tail distances after one
round of amplification, which were lost after two rounds
(Figure 5C). The differential expression of these inconsist-
ent genes were validated by qRT-PCR, confirming that a
second round of amplification resulted in a 30% reduc-
tion of truly differentially expressed genes when probes
are located >500 nt from the poly(A)-tail. Thus, it is
important to realize that differentially expressed genes can
only be identified for those genes that have a short probe
– poly(A)-tail distance, especially after two rounds of
amplification. Genes with probe-poly(A)-tail distances of
more than 500 nt can be falsely classified as being not dif-
ferentially expressed. Improvement of microarray probe
design may help to circumvent the bias introduced by the
amplification method, which is currently not optimal for
samples with limited amounts of RNA.
We microdissected an area of approximately 25 × 106 μm2
tumor or bronchial epithelial tissue in approximately 4
hours for each sample. This amount of tissue yielded ~300
ng of total RNA. Although quite labor intensive, this
approach allows the isolation of sufficient RNA to apply
the more reliable approach including only one round of
amplification, since the minimally advised starting
amount is 100 ng (Ambion). In general, areas of cell types
abundantly present in selected tissue sections, such as
squamous cells in non-small cell lung cancer or bronchial
epithelial cells in airway tissue, allows isolation of suffi-
cient total RNA in a relatively short time to perform only
one round of amplification. However, in the case of single
cell research it is clearly not realistic to yield sufficient
RNA for one round of amplification.
Conclusion
This study showed that differentially expressed genes, for
which the microarray probe is not selected from a region
close to the poly(A)-tail, will remain undetected in gene
expression profiles obtained after two rounds of amplifi-
cation. We demonstrated a loss of 30% of truly differen-
tially expressed genes, which may lead to incomplete data
with respect to key pathways in the cell type of interest.
This study strongly supports the use of a single round of
amplification where possible. Additionally, our results
Principal component analysis of 12 individual hybridizationsFigure 3
Principal component analysis of 12 individual hybridi-
zations. Each hybridization result is illustrated as a colored 
circle in a 3D graph. The similar the color, the similar the 
sample. The 2nd, 3rd and 4th components are demonstrated 
on the x-, y- and z-axis respectively with negative and posi-
tive values. The 2nd component explains differences in 
expression of tumor and bronchus (negative values (red-
orange) are bronchus, positive values (blue-green) are tumor 
samples). The 3rd component explains the differences in 
number of amplification rounds (negative values (orange and 
green) are one round amplified, positive values (red and blue) 
are two rounds amplified) and the 4th component explains 
the labeling type of Cy-dye (negative values (light colored) 
are Cy3 labeled, positive values (dark colored) are Cy5 
labeled samples).Page 5 of 13
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dures and innovative microarray probe design to allow
reliable detection of differentially expressed genes for
samples with limited amounts of RNA.
Methods
Tissue specimens
A tumor and a normal bronchus tissue sample were
obtained from two patients with squamous cell lung car-
cinoma (SCC) during surgery at University Medical
Center Groningen. The tissues were snap frozen in liquid
isopentane, and stored at -80°C until further processing.
Written informed consent was obtained from the patients.
Laser microdissection microscopy
To obtain pure cell populations, we performed laser
microdissection microscopy (LDM) [1]. Briefly, frozen
sections of 8 μm from lung tissue were mounted on poly-
L-lysine coated polyethylene naphthalene membrane-
covered slides (P.A.L.M., Bernried, Germany). Air-dried
sections were lightly stained with RNase free heamatoxy-
lin (20s), rinsed with DEPC-H2O, dehydrated with 100%
ethanol and air-dried. Tumor cells were microdissected
from tumor sections and histological normal bronchus
epithelial cells were microdissected from bronchus sec-
tions. An area of approximately 20 to 25 × 106 μm2 was
microdissected by the P.A.L.M. Microlaser Technology
system, according to the manufacturer's instructions
Bland and Altman plotsFigure 4
Bland and Altman plots. Bland and Altman plots show a large variability between one (1x) and two rounds (2x) of amplifica-
tion for (A) T1 and (B) T2 with wide 95% limits of agreement of -0.7 to 0.7. The variability within the same amplification 
method is much smaller for as well (C) 1× as (D) 2x, both with much narrower 95%-limits of agreement of -0.3 to 0.3. No sys-
tematic bias was found. As an example, only Cy5 is shown here. T1-1x, tumor – one round of amplification; T1-2x, tumor – 
two rounds of amplification; T2-1x, duplicate tumor – one round of amplification; T2-2x, duplicate tumor – two rounds of 
amplification; dotted line, 95%-limits of agreement.Page 6 of 13
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Probe – poly(A)-tail distance in relation to differentially expressed genesFigure 5
Probe – poly(A)-tail distance in relation to differentially expressed genes. A, Boxplot of probe – poly(A)-tail dis-
tances for 21,103 Agilent WHG probes (median 542 nt, range, 0–22,006) (all genes); B, Boxplot of probe – poly(A)-tail dis-
tances for the 872 differentially expressed genes after one round (median 289, range, 0–7090) (one round) and 839 
differentially expressed genes after two rounds (median 212, range, 0–7621) (two rounds). Mann Whitney analysis revealed a 
significant decrease of the probe – poly(A)-tail distance after two rounds as compared to one round of amplification (p < 
0.0001); C, 246 of the 872 genes (~30%) differentially expressed after one round are not identified as being differentially 
expressed after two rounds of amplification (lost in 2nd). These 246 genes have a significant longer probe – poly(A)-tail distance 
as compared to the remaining 626 genes which were identified as differentially expressed for both one and two rounds of 
amplification (persistent in 2nd) (Mann Whitney: p < 0.0001). Ten of these inconsistent genes, with a probe – poly(A)-tail dis-
tance of more than 500 nt, were selected for validation with qRT-PCR;
BMC Genomics 2007, 8:277 http://www.biomedcentral.com/1471-2164/8/277(P.A.L.M.) and microdissected cells were immediately col-
lected in lysis buffer (Macherey-Nagel, Düren, Germany).
RNA isolation
Total RNA was isolated and purified from the laser-dis-
sected cells with a Nucleospin RNA II kit (Macherey-
Nagel), according to the manufacturer's instructions,
including DNase treatment. The quantity of DNA-free
total RNA was measured using a Nanodrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE). RNA quality was assessed by the presence and
ratio of 18S and 28S rRNA bands combined with a low
baseline, monitored with RNA 6000 PicoChip (Agilent,
Palo Alto, CA) on the 2100 bioanalyzer (Agilent).
Microarray approach
Agilent Whole Human Genome (WHG) Oligo Microar-
rays (Agilent, Palo Alto, CA), containing 44,000 60-mer
oligonucleotides representing over 41,000 human genes
and transcripts, were used to study gene expression levels
in laser microdissected squamous lung carcinoma cells
and bronchial epithelial cells. A duplicate of the microdis-
sected tumor sample (T1 and T2) and the microdissected
bronchial epithelium (B) were amplified for one or two
rounds using a total RNA input of 100 ng or 25 ng, respec-
tively. mRNA amplification was performed using Mes-
sageAmp II (Ambion, Austin, USA). The main difference
between one and two rounds of amplification is the use of
different primers. Briefly, the first round of amplification
was performed starting with T7 Oligo(dT) primers and the
second round of amplification was performed starting
with random hexamer primers. mRNA amplification,
labeling, hybridization and data extraction were per-
formed at ServiceXS (Leiden, The Netherlands) according
to manufacturer's instructions. A dye swap was included
and the samples were hybridized using a randomized
approach (Table 2), based on the non-competitive condi-
tions of a two-color array [15].
Statistical analyses of microarray data
To achieve a normal distribution in the data of the Agilent
WHG microarray experiments, the median signals of the
spot intensities of each hybridization were log2 trans-
formed and standardized to mean = 0 and SD = 1 (log
intensities). Principal component analysis (PCA) – a mul-
tivariate data analysis tool – was performed to identify fac-
tors that explain the largest variance between the
individual datasets [16-18]. The first principal component
was deducted from the normalized data matrix. This data-
Table 1: Selected differentially expressed genes and results of validation with qRT-PCR
Gene Up-/Down- regulation in T versus B Probe – poly(A)-tail distance (nt) Relative expression levels (AU)
T B
lost in two rounds (figure 5C):
SLC1A6 Up 803 106 1
PTHLH Up 1,096 69 1
DKK3 Up 1,104 14 1
CGN Down 693 1 363
IL18 Down 715 1 7
PTGFR Down 835 1 40
CCND1 Down 965 1 21
DAF Down 1,016 1 3
KRT7 Down 1,026 1 35
NCOA7 Down 2,106 1 0.7
persistent in two rounds (figure 5C):
SOST Up 891 741 1
MCM6 Up 1,039 29 1
SDC2 Up 2,530 108 1
CAPS Down 573 1 19
B2M Down 648 1 1.6
NME5 Down 704 1 798
DCN Down 816 1 19
NS3TP2 Down 820 1 24
GSTA1 Down 824 1 14
UBXD3 Down 1,738 1 72
T, tumor; B, bronchus; nt, nucleotides; AU, arbitrary units.Page 8 of 13
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Probe – poly(A)-tail distance in relation to overall signal intensityFigure 6
Probe – poly(A)-tail distance in relation to overall signal intensity. For each of the 21,103 genes, the average signal 
intensity was calculated for one and two rounds of amplification for both sample types (T or B) separately. Per sample type, the 
average signal intensity after one round was subtracted from the average signal intensity after two rounds of amplification (2x/
1x ratio). The 2x/1x ratios were plotted against the 10log of their corresponding probe – poly(A)-tail distance. A negative 
regression coefficient for both T and B samples was shown, significantly different from zero (p < 0.0001), that indicates a 
decrease in overall detection after two rounds of amplification with an increase in probe – poly(A)-tail distance. T, tumor; B, 
bronchus; 2x, two rounds of amplification; 1x, one round of amplification
BMC Genomics 2007, 8:277 http://www.biomedcentral.com/1471-2164/8/277set of standardized log intensities were used for further
analysis.
We compared the duplicate datasets of the tumor sample
of one round of amplification with those of two rounds of
amplification. In addition, we included comparisons
within the same amplification method as a control. Data-
sets with the same Cy-dye labeling were compared to pre-
clude possible influence by different Cy-dye labels. First,
we constructed Bland and Altman plots to assess agree-
ment between one and two rounds of amplification
[19,20]. Any systemic bias or other differences between
the two methods can be assessed by eye. In correspond-
ence with the graphical methods of Bland and Altman, we
applied the Bradley-Blackwood F test to assess whether
the means and differences of expression can be considered
to be equal [21]. We determined Pearson correlation coef-
ficients, which measures the degree of linear relationship
between two datasets. In addition, we computed concord-
ance correlation coefficients on the selected datasets. The
concordance correlation, i.e. rho_concordance with 95%
confidence intervals, is a more appropriate way to assess
agreement since this test evaluates the degree to which the
pairs of observations of the two amplification methods
fall on the 45° line through the origin [19,22,23]. STATA
was used to construct Bland and Altman plots, perform
the Bradley-Blackwood F test and calculate the concord-
ance correlation coefficients. P-values of <0.05 were con-
sidered to be statistically significant.
Selection of differentially expressed genes
To identify differentially expressed genes between the
duplicate tumor samples (T1 and T2) and the bronchus
sample (B), the ratio was calculated for the two amplifica-
tion approaches separately from the standardized dataset
(see statistical analyses). Briefly, tumor-bronchus ratios
(T/B) were determined by subtracting two times the log
intensities of the bronchus from the sum of log intensities
of the duplicate tumor for both Cy-dyes according to the
following formula: (T1+T2) - 2*B. These T/B ratios were
calculated for the one and two rounds of amplification
samples separately. By comparing the ratios of Cy3 with
Cy5 at a threshold of two times the standard deviation
(2×SD), consistent differentially expressed genes (p <
0.05) were identified. Specifically, to select upregulated
genes in tumor compared with bronchus we used the for-
mula: [T/B(Cy3) > [meanT/B(Cy3) + 2×SD(Cy3)] and T/
B(Cy5) > [meanT/B(Cy5) + 2×SD(Cy5)]]. We selected
downregulated genes based on the formula: [T/B(Cy3) <
[meanT/B(Cy3) - 2×SD(Cy3)] and T/B(Cy5) < [meanT/
B(Cy5) - 2×SD(Cy5)]]. Additionally, the number of differ-
entially expressed genes was similarly determined with a
threshold at 3×SD (p < 0.003) and 4×SD (p < 0.0001).
Retrieving probe – poly(A)-tail distances
Since a list of probe – poly(A)-tail distances of the Agilent
WHG array is not available, we determined the position of
the 60 mer-oligos (probes) in the transcript sequence of
their corresponding genes. The sequences of these Agilent
WHG probes were retrieved from the website of Agilent
[24]. A batch-MegaBLAST was performed within the
human refseq mRNA database from NCBI build 36.2
using the probe sequences as query [25]. The retrieved
mRNA sequences were filtered to be proven mRNAs
(including only "NM_" and "NR_" mRNAs) with a mini-
mal overlap of 57 bases to the input sequence and a min-
imal identity of 95%. The accession number of the mRNA
refseq sequence was used to retrieve the transcript length
from the refSeqAli database at the UCSC Table Browser of
build Hg18 [26]. 27,590 refseq hits were retrieved for
22,388 Agilent WHG probes. The probe – poly(A)-tail dis-
tances of these 22,388 probes were calculated by subtract-
ing the probe position from the transcript length (see
Additional file 1). For 21,103 out of these 22,388 probes,
a unique probe – poly(A)-tail distance could be deter-
mined. The remaining 1,285 probes provided more than
Table 2: Randomized hybridization design on Agilent WHG arrays
Data set Sample Number of amplification rounds Dye label Array number
1 T1 1x Cy3 3
2 T1 1x Cy5 1
3 T2 1x Cy3 1
4 T2 1x Cy5 2
5 B 1x Cy3 2
6 B 1x Cy5 3
7 T1 2x Cy3 6
8 T1 2x Cy5 4
9 T2 2x Cy3 4
10 T2 2x Cy5 5
11 B 2x Cy3 5
12 B 2x Cy5 6
T1, microdissected tumor sample; T2, duplicate microdissected tumor sample; B, microdissected bronchial epithelial sample.Page 10 of 13
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resulted in different probe – poly(A)-tail distances. These
1,285 probes were therefore excluded from further analy-
sis.
Quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) was used to validate dif-
ferential gene expression. Primers of 20 selected genes and
the housekeeping gene RNA polymerase II (RPII) were
designed using Primer Express software (Applied Biosys-
tems, Foster City, CA). Where possible, primer sequences
were chosen to span exon junctions to prevent genomic
DNA amplification. Primer sequences of the 20 selected
genes and RPII are shown in Table 3. cDNA was synthe-
sized from DNase-treated total RNA isolated from the
microdissected tumor and bronchus samples using Super-
script II Reverse Transcriptase (Invitrogen, Carlsbad, CA)
with random primers (Invitrogen) according to the man-
ufacturer's instructions. qRT-PCR reactions were per-
formed in triplicate in a 20-μl reaction volume containing
1× SYBRgreen mix (Applied Biosystems, Foster City, CA),
900 nmol/l primers and 1 ng cDNA. Reactions were per-
formed on an ABI7900HT Sequence Detection System
device (PE Applied Biosystems) using the standard pro-
gram (10 min at 95°C followed by 40 cycles of 15 s at
95°C, and 60 s at 60°C). Reaction tubes without template
cDNA served as negative controls. RPII was used for nor-
malization. The relative amount of transcripts was calcu-
lated by subtracting the average Ct value of the reference
gene RPII from the average Ct value of the individual
Table 3: Primers of 20 selected differentially expressed genes between tumor and bronchus, used for validation with qRT-PCR
Gene Accession number Primers (5'→3') Product (bp)
SOST NM_025237 FW-CGCTGCCCATCAGAAAGC
REV- CAGGACTAGAAACCACATCTACAGTTG
76
MCM6 NM_005915 FW-GGACCTTTCTTATAGGCTGGTCTTTC
REV- GCTCTTTCCCCCCAAACCT
74
SDC2 NM_002998 FW-GAGTGTATCCTATTGATGACGATGACTAC
REV- CTCTGGACTCTCTACATCCTCATCAG
77
CAPS NM_004058 FW-AGGTCACACTGGCGGAATTC
REV- GGTCATCATGGCCACGAACT
86
B2M NM_004048 FW-GAAAAAGTGGAGCATTCAGACTTG
REV- ATGATGCTGCTTACATGTCTCGAT
174
NME5 NM_003551 FW-AACTCTGCTTGAAGGACTCACAGA
REV- CAGCCAATCAGCTAGCCAAAT
76
DCN NM_001920 FW-GCTGTCAATGCCATCTTCGA
REV- GGGAAGATCCTTTGGCACTTT
71
NS3TP2 NM_023927 FW-TGCTTCCTGAGGCGTTTTG
REV- CATGCAATGTCTGGATTCTCATC
76
GSTA1 NM_145740 FW-GCTACTTCCCTGCCTTTGAAAA
REV- GCCCGGCTCAGCTTGTT
76
UBXD3 NM_152376 FW-GCCAAGGGACGGACAAGAC
REV- AGGCGGAGATGGTATATGATGAG
78
SLC1A6 NM_005071 FW-CTTCAAACAGTTCAAGACGCAGTAC
REV- CGGCTCAGACCCGTTCTCT
79
PTHLH NM_002820 FW-CCGC4CTCAAAAGAGCT715GTGT
REV- CGCCGTAAATCTTGGATGGA
72
DKK3 NM_013253 FW-AGGAGCCACGAGTGCATCA
REV- GGTGTACTGGAAGCTGGCAAAC
75
CGN NM_020770 FW-TGAGGAATTCGACAGTGTCTACGA
REV- GGTCTGTAGGTTGCTCTCCGTAA
70
IL18 NM_001562 FW-AGGAACCTCAGACCTTCCAGATC
REV- CTACTGGTTCAGCAGCCATCTTT
81
PTGFR NM_000959 FW-GGCCTGGGATGACAAGATGT
REV- TTGTGGAGATAAAAGCCAACCA
86
CCND1 NM_053056 FW-CCGTCCATGCGGAAGATC
REV- CCTCCTCCTCGCACTTCTGT
69
DAF NM_000574 FW-TGCCCTAATCCGGGAGAAA
REV- GAAGGAGATGGTTGCACCAAA
78
KRT7 NM_005556 FW-GCCACCACCCACAATCACA
REV- CTTTCCAGACTGTCTCACTGTCTTG
79
NCOA7 NM_181782 FW-TATGTGGCGGGCACCTGTA
REV- CTCTGCTTCCCGGATTCAAG
75
RPII Housekeeping gene FW- CGTACGCACCACGTCCAAT
REV- CAAGAGAGCCAAGTGTCGGTAA
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(page number not for citation purposes)
BMC Genomics 2007, 8:277 http://www.biomedcentral.com/1471-2164/8/277selected genes (ΔCt). Next, ΔΔCt values were calculated by
subtracting the ΔCt of the tissue type with the lowest
expression for that particular gene from the ΔCt of the tis-
sue type with the highest expression (upregulation). Sub-
sequently, relative expression levels were defined as 2-ΔΔCt,
resulting in the factor of up- or down-regulation between
tumor and bronchus.
Calculation of signal intensity ratios between one and two 
rounds of amplification
To investigate if a long probe – poly(A)-tail distance neg-
atively influences the overall signal intensity of genes after
two rounds of amplification, the difference in signal
intensity between one and two rounds of amplification
(2x/1x ratio) was calculated for each probe. Briefly, genes
with no or low expression were first excluded from this
analysis by deleting all genes with a median signal inten-
sity smaller than three times the background signal inten-
sity. Next, we calculated the 2x/1x ratio for both samples
(T and B) separately by subtracting the average signal
intensities of the standardized dataset (see statistical anal-
yses) obtained after one round from those obtained after
two rounds of amplification. These 2x/1x ratios were plot-
ted against their corresponding probe – poly(A)-tail dis-
tance.
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